Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04907253
PHASE2

Quercetin in Coronary Artery By-pass Surgery

Sponsor: Montreal Heart Institute

View on ClinicalTrials.gov

Summary

The purpose of this study is to test the anti-inflammatory and anti-senescence effects of quercetin during coronary artery by-pass graft surgery.

Official title: Étude randomisée contrôlée Par Placebo de Phase II Visant à Mesurer l'Effet Anti-inflammatoire et Anti-sénescence de la quercétine Lors d'Une Chirurgie Cardiaque

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2021-06-04

Completion Date

2025-09-01

Last Updated

2025-05-08

Healthy Volunteers

No

Interventions

DRUG

Quercetin

500 mg twice daily

DRUG

Placebo

twice daily

Locations (1)

Montreal Heart Institute

Montreal, Quebec, Canada